The 2'-O- and 3'-O-Cy3-EDA-ATP(ADP) complexes with myosin subfragment-1 are spectroscopically distinct. 2003

Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
Kanasi Advanced Research Center, Kobe 651-2492, Japan.

Ribose-modified highly-fluorescent sulfoindocyanine ATP and ADP analogs, 2'(3')-O-Cy3-EDA-AT(D)P, with kinetics similar to AT(D)P, enable myosin and actomyosin ATPase enzymology with single substrate molecules. Stopped-flow studies recording both fluorescence and anisotropy during binding to skeletal muscle myosin subfragment-1 (S1) and subsequent single-turnover decay of steady-state intermediates showed that on complex formation, 2'-O- isomer fluorescence quenched by 5%, anisotropy increased from 0.208 to 0.357, and then decayed with turnover rate k(cat) 0.07 s(-1); however, 3'-O- isomer fluorescence increased 77%, and anisotropy from 0.202 to 0.389, but k(cat) was 0.03 s(-1). Cy3-EDA-ADP.S1 complexes with vanadate (V(i)) were studied kinetically and by time-resolved fluorometry as stable analogs of the steady-state intermediates. Upon formation of the 3'-O-Cy3-EDA-ADP.S1.V(i) complex fluorescence doubled and anisotropy increased to 0.372; for the 2'-O- isomer, anisotropy increased to 0.343 but fluorescence only 6%. Average fluorescent lifetimes of 2'-O- and 3'-O-Cy3-EDA-ADP.S1.V(i) complexes, 0.9 and 1.85 ns, compare with approximately 0.7 ns for free analogs. Dynamic polarization shows rotational correlation times higher than 100 ns for both Cy3-EDA-ADP.S1.V(i) complexes, but the 2'-O-isomer only has also a 0.2-ns component. Thus, when bound, 3'-O-Cy3-EDA-ADP's fluorescence is twofold brighter with motion more restricted and turnover slower than the 2'-O-isomer; these data are relevant for applications of these analogs in single molecule studies.

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009038 Motion Physical motion, i.e., a change in position of a body or subject as a result of an external force. It is distinguished from MOVEMENT, a process resulting from biological activity. Motions
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D005454 Fluorescence Polarization Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. Anisotropy, Fluorescence,Fluorescence Anisotropy,Polarization, Fluorescence,Anisotropies, Fluorescence,Fluorescence Anisotropies,Fluorescence Polarizations,Polarizations, Fluorescence
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D015879 Myosin Subfragments Parts of the myosin molecule resulting from cleavage by proteolytic enzymes (PAPAIN; TRYPSIN; or CHYMOTRYPSIN) at well-localized regions. Study of these isolated fragments helps to delineate the functional roles of different parts of myosin. Two of the most common subfragments are myosin S-1 and myosin S-2. S-1 contains the heads of the heavy chains plus the light chains and S-2 contains part of the double-stranded, alpha-helical, heavy chain tail (myosin rod). Actomyosin Subfragments,Meromyosin Subfragments,Myosin Rod,Myosin S-1,Myosin S-2,ATPase, Actin-S1,Actin S1 ATPase,Actoheavy Meromyosin,Actomyosin Subfragment 1 ATPase,H-Meromyosin,Heavy Meromyosin,Heavy Meromyosin Subfragment-1,Heavy Meromyosin Subfragment-2,Light Meromyosin,Myosin Subfragment-1,Myosin Subfragment-2,ATPase, Actin S1,Actin-S1 ATPase,H Meromyosin,Heavy Meromyosin Subfragment 1,Heavy Meromyosin Subfragment 2,Meromyosin Subfragment-1, Heavy,Meromyosin Subfragment-2, Heavy,Meromyosin, Actoheavy,Meromyosin, Heavy,Meromyosin, Light,Myosin S 1,Myosin S 2,Myosin Subfragment 1,Myosin Subfragment 2,Subfragment-1, Heavy Meromyosin,Subfragment-1, Myosin,Subfragment-2, Heavy Meromyosin,Subfragment-2, Myosin,Subfragments, Actomyosin,Subfragments, Meromyosin,Subfragments, Myosin
D016880 Anisotropy A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions. Anisotropies

Related Publications

Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
January 1991, Biochemistry,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
May 1993, Journal of biomolecular NMR,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
April 1991, Biochemistry,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
January 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
October 1974, European journal of biochemistry,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
September 1995, FEBS letters,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
October 1987, The Journal of biological chemistry,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
October 1993, Biochemistry,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
August 1983, Proceedings of the National Academy of Sciences of the United States of America,
Kazuhiro Oiwa, and David M Jameson, and John C Croney, and Colin T Davis, and John F Eccleston, and Michael Anson
October 1994, Biochemistry,
Copied contents to your clipboard!